Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ)

CNY 17.07

(1.01%)

Market Cap (In CNY)

4.36 Billion

Revenue (In CNY)

1.13 Billion

Net Income (In CNY)

361.82 Million

Avg. Volume

1.7 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
12.614285-19.607141
PE
-
EPS
-
Beta Value
0.251
ISIN
CNE100000NJ9
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Fujun Wang
Employee Count
-
Website
https://www.lishengpharma.com
Ipo Date
2010-04-23
Details
Tianjin Lisheng Pharmaceutical Co.,Ltd. engages in the production and sale of chemical medicines. The company offers tablets, hard capsules, dripping pills, freeze-dried powder injections, water injections, and bulk medicines, as well as intermediates, diagnostic reagents, biochemical reagents, and plastic bottles. It also exports its products. The company is based in Tianjin, China. Tianjin Lisheng Pharmaceutical Co.,Ltd. operates as a subsidiary of Tianjin Pharmaceutical Holdings Co., Ltd.